secwatch.observer — SEC 8-K summary
======================================

Issuer:     Cencora, Inc. (COR)
CIK:        0001140859
Form:       8-K
Filed at:   2026-02-10T23:59:59+00:00
Accession:  0001140859-26-000012
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Cencora reorganizes segments; explores strategic alternatives for MWI Animal Health, Profarma, U.S. Consulting Services
--------------------------------------------------------------------------------

- New segments: U.S. Healthcare Solutions, International Healthcare Solutions, and Other.
- Other includes MWI Animal Health, Profarma, U.S. Consulting Services, and legacy Pharmalex components under strategic review.
- Segment reporting change effective Q1 FY2026; historical segment data in 2025 10-K revised but consolidated financials unchanged.
- No updates on events after November 25, 2025; first quarter FY2026 10-Q filed February 4, 2026.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1140859/000114085926000012/0001140859-26-000012-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1140859/000114085926000012/cor-20260210.htm
  HTML page:      https://secwatch.observer/filing/0001140859-26-000012

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer